At Adaptive Biotechnologies, we’ve spent over a decade building our proprietary immune medicine platform to decode the adaptive immune system, to learn how it naturally detects and fights a multitude of diseases. Through a collaboration with Microsoft, we are using our platform and Microsoft’s AI and Machine Learning to develop a TCR-antigen map – a map of T cells, the first responders of the adaptive immune system, to the antigens they bind. Using this data, we aim to translate the natural diagnostic capability of the immune system into the clinic. When the pandemic began, we extended our platform to COVID-19 to develop the first-ever T cell-based clinical test that can detect an immune response to recent or past COVID-19 infection.
Email: media@adaptivebiotech.com